Barcelona (Spain), July 17, 2025 — Applus+, a global leader in testing, inspection and certification, is proud to announce the acquisition of Notice Belgelendirme Muayene ve Denetim Hizmetleri A.Ş. (“Notice”), a Notified Body for Medical Devices, headquartered in Kartal, Istanbul Province, Turkey, with additional operations in Slovenia. The new company will become part of Applus+ Laboratories.
This acquisition marks a significant milestone in Applus+ Laboratories’ journey as a leader in the medical devices industry. By integrating Notice’s regulatory expertise with our global testing infrastructure, we can now offer our clients a one-stop-shop solution. This includes product testing, product certification in Europe, and system certification. Such an integrated service portfolio serves companies navigating the complex and evolving regulatory landscape of the medical device industry, including the MDR transition, enabling them to bring safer, more effective products to market.
With laboratories across Europe, North America, and Asia, Applus+ Laboratories has built a strong foundation in medical device testing. Our capabilities span biomechanical testing, chemical testing including biocompatibility, packaging testing, EMC and electrical safety, cybersecurity, and specialized services for implants and dental devices. Our laboratory accreditations allow us to meet regulatory requirements in key global markets, including the FDA in the United States and the NMPA in China. With the addition of Notice as a Notified Body under MDR in Europe, we now offer a global compliance pathway — enabling our clients to demonstrate compliance across all major regulatory frameworks.
Founded in 2016, Notice is designated as a Notified Body under MDR (NB 2764) and accredited by TÜRKAK under ISO 17021 to certify quality management systems in accordance with ISO 13485. The company exclusively serves the medical device sector, assessing manufacturers’ compliance with the rigorous regulatory requirements of the European market.
“We are delighted to welcome Notice to Applus+ Laboratories. Their proven expertise in MDR certification significantly enhances our ability to serve as a comprehensive regulatory gateway for medical device manufacturers worldwide. Notice completes our business portfolio, enabling us to provide a fully integrated service that merges global testing capabilities with expert regulatory approval services for major international markets” said Mauricio Úbeda, EVP at Applus+ Laboratories.
“Joining Applus+ Laboratories is a major opportunity for Notice. Being part of a group with such advanced testing infrastructure allows us to offer our clients a broader and more integrated service. Together, we are creating a stronger value proposition for medical device manufacturers, contributing to innovation and ensuring patient safety” said Ilker Eker, Co-Founder and CEO at Notice.
As the medical device industry navigates the transition from Medical Device Directive (MDD) to the new Medical Device Regulation (MDR), Applus+ Laboratories is committed to being a trusted partner —providing conformity assessment services for medical devices manufacturers to demonstrate regulatory demands while accelerating innovation that improves lives.
Applus+ is one of the world’s leading companies in the testing, inspection, and certification sector. We are a trusted partner that helps clients enhance the quality and safety of their assets and operations while safeguarding their environmental performance. Our technical capability, innovation, and highly qualified team of more than 28,000 professionals allow us to ensure operational excellence across a wide range of sectors in over 65 countries.
We offer a comprehensive portfolio of solutions to meet a variety of needs, from asset management to regulatory inspections. At Applus+, we maintain a strong commitment to technological development, digitalisation, and the constant updating of our knowledge of standards and regulatory requirements.
Applus+ Laboratories is a division of the Applus+ Group, dedicated to providing testing and certification services to enhance the competitiveness of our clients' products and foster innovation.
We are headquartered in Barcelona, Spain, and our expanding network of multidisciplinary laboratories around the world plays a crucial role in advancing the industries we serve, including aerospace, automotive, cybersecurity, electrical and electronics, renewable energies, construction, railway, and medical devices.
Our state-of-the-art facilities, deep expertise, and advanced capabilities allow us to collaborate with leading technological corporations globally. We are eager to partner with you to help meet your market needs and drive your success.
Applus+ uses first-party and third-party cookies for analytical purposes and to show you personalized advertising based on a profile drawn up based on your browsing habits (eg. visited websites). Click HERE for more information. You can accept all cookies by pressing the "Accept" button or configure or reject their use by clicking here.
They allow the operation of the website, loading media content and its security. See the cookies we store in our Cookies Policy
They allow us to know how you interact with the website, the number of visits in the different sections and to create statistics to improve our business practices. See the cookies we store in our Cookies Policy